Nasdaq approved the listing of Canary Capital’s Staked INJ ETF on November 4, 2026, opening a pathway for Injective’s INJ token to enter the regulated U.S. securities market and potentially earn staking rewards. The approval of this ETF is seen as an institutional milestone for Injective, though trading has not yet begun. Meanwhile, the INJ price has rebounded to approximately $7.64, breaking above a closely watched resistance level.
Summary
- Canary Capital's Staked INJ ETF has received approval for listing on Nasdaq.
- The fund combines INJ exposure with potential staking rewards.
- INJ rose approximately 9% in 24 hours to around $7.64.
- Listing approval and the official commencement of ETF trading are two distinct steps.
Injective's INJ ETF has been approved, paving the way for regulated investment.
Through Canary Capital’s Staked INJ ETF, INJ now has its first regulated exchange-traded product available in the United States. This product structure combines traditional investment channels with staking exposure to crypto, offering investors an alternative to holding tokens directly.
This fund allows investors to gain exposure to INJ and potential staking rewards without having to manage the tokens or set up staking infrastructure themselves. Its exchange-traded structure also makes it easier for investors who prefer traditional brokerage accounts to access this asset.
According to Eagle.inj, this approval reflects years of development, innovation, and ecosystem growth. For Injective, this milestone opens a channel to access institutional demand through regulated securities market products.
However, listing approval does not equate to immediate trading commencement. The fund's launch and subsequent investor participation remain independent developments; approval alone does not indicate demand levels.
INJ broke above $7.30, but technical signals remain mixed.
INJ has rebounded to approximately $7.64, surpassing the $7.30 breakout level identified by crypto analyst Trader Symba. Market data shows a 9% increase over the past 24 hours.
Trader Symba stated that INJ has broken out of the wedge pattern and successfully retested the breakout area. The analyst views $7.30 as a resistance level already overcome by buyers, with an initial target at $7.55 and higher extended targets between $8.00 and $8.20.
The $7.64 price mentioned in the report has already exceeded this initial target. The higher range remains a conditional forecast, dependent on whether buying pressure can be sustained and the breakout structure maintained.
The moving averages provide less clear signals. INJ's price is above the 7-day moving average but remains below the 20-day moving average, which is near $7.92. Its Relative Strength Index is around 50, indicating neutral momentum rather than clear confirmation of a stronger uptrend.
The ETF launch and $7.92 will be the next test.
The eventual launch of trading and initial fund inflows into the Staked INJ ETF will more clearly reflect institutional demand. From a price chart perspective, if the price can sustainably hold above $7.92, it will help reinforce this rebound and bring Trader Symba’s higher target range into view.
The approval of the Injective INJ ETF and the token's breakout represent two distinct developments: the former establishes an exchange listing channel, while the latter reflects a price rebound in the news. The actual participation in the fund will provide evidence of investor interest beyond the approval itself.
From a technical perspective, sustained buying pressure remains a prerequisite for the higher price targets to be valid. After the breakout, $7.30 can serve as a reference level of support, while the 20-day moving average is located at approximately $7.92.
This article was generated with the assistance of artificial intelligence and reviewed by the editorial team.
Amelia Tomasicchio
As a digital marketing expert, Amelia entered the fintech industry in 2014 after writing a technical paper on Bitcoin. She previously contributed to several international cryptocurrency magazines and served as Chief Marketing Officer at Eidoo. She is currently a co-founder of The Cryptonomist and a marketing instructor at Milan Digital Coach. She has also authored a book on NFTs for Mondadori Publishing and has helped artists and companies enter this space. As a consultant, Amelia has been involved in metaverse-related projects such as The Nemesis and OVER.